High Capacity and Reversible Fragile Watermarking Method for Medical Image Authentication and Patient Data Hiding.

Autor: Bouarroudj R; LRIA, Department of Computer Science, University of Science and Technology Houari Boumediene (USTHB), B.P. 32, El Alia, 16111 Bab Ezzouar, Algiers, Algeria. rbouarroudj@usthb.dz., Bellala FZ; LRIA, Department of Computer Science, University of Science and Technology Houari Boumediene (USTHB), B.P. 32, El Alia, 16111 Bab Ezzouar, Algiers, Algeria., Souami F; LRIA, Department of Computer Science, University of Science and Technology Houari Boumediene (USTHB), B.P. 32, El Alia, 16111 Bab Ezzouar, Algiers, Algeria.; Department of Computer Science, University of Algiers 1, Algiers, Algeria.

Publikováno v: Journal of medical systems [J Med Syst] 2024 Oct 19; Vol. 48 (1), pp. 98. Date of Electronic Publication: 2024 Oct 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer

Autor: Colombo, N. Kutarska, E. Dimopoulos, M. Bae, D.-S. Rzepka-Gorska, I. Bidzinski, M. Scambia, G. Engelholm, S.A. Joly, F. Weber, D. El-Hashimy, M. Li, J. Souami, F. Wing, P. Engelholm, S. Bamias, A. Schwartz, P.

Purpose: This study compared the efficacy and safety of patupilone with those of pegylated liposomal doxorubicin (PLD) in patients with platinum-refractory or -resistant epithelial ovarian, primary fallopian tube, or primary peritoneal cancer. Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c9b5a27aac281e825e296c77605547b2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3089197

2LBA - Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

Autor: Sonke, G.S., Hart, L.L., Campone, M., Erdkamp, F., Janni, W., Verma, S., Villanueva, C., Jakobsen, E., Alba, E., Wist, E., Favret, A.M., Bachelot, T., Hegg, R., Wheatley-Price, P., Souami, F., Sutradhar, S., Miller, M., Germa, C., Burris, H.A.

Publikováno v: In European Journal of Cancer February 2017 72 Supplement 1:S1-S2

LBA1 First-line ribociclib 1 letrozole in postmenopausal Asian women with hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2

Autor: Yap, Y.S., Tseng, L.-M., Blackwell, K.L., Cameron, D., Foo, S., Sriuranpong, V., Huang, C.-S., Chao, T.-Y., Kim, T.-Y., Chen, S.-C., Jung, K.H., Lee, K.S., Sohn, J.-H., Kim, J.H., Hou, M.-F., Han, Y., Souami, F., Dhuria, S., Miller, M., Verma, S.

Publikováno v: In Annals of Oncology December 2016 27 Supplement 9:ix190-ix190